Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sulfotransferase family, cytosolic, 1D, member 1, pseudogene (SULT1D1P) is a human gene classified as a pseudogene because it has been inactivated by mutation and does not produce a functional protein[1]. Sulfotransferase enzymes, in general, are involved in the sulfate conjugation of various hormones, neurotransmitters, drugs, and xenobiotics[1][9], but SULT1D1P itself does not perform these functions in humans. It is listed among the cytosolic sulfotransferase family members, but its status as a pseudogene means it has no known physiological or therapeutic relevance, no protein product, and no disease or pharmacological significance[1][9]. Key clarification: - SULT1D1P is not a receptor, enzyme, or transporter but rather a non-functional genetic relic[1][9]. - Any reference to "activity," "drug interaction," or "biological function" pertains to functional members of the SULT family, not SULT1D1P[1][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sulfotransferase family, cytosolic, 1D, member 1, pseudogene (SULT1D1P).